Home - Servier

Servier: an international
pharmaceutical group
governed by a non-profit foundation

We are focused on
cardiovascular diseases, cancer, diabetes,
immune-inflammatory and neuropsychiatric diseases

We contribute to transmit to future generations
a world that can ensure
access to quality health care for all

We are committed to therapeutic progress
to serve patient needs

News

Press Release

Servier, in the top 5 companies favoured by students and young graduates 10 / 18 / 2018

Press Release

Kurma Partners announces the first closing of  Kurma Biofund III 12 / 14 / 2018

Decoded content

Hypertension: a silent killer 12 / 10 / 2018

News

[Mécénat Servier] Discover the testimony of Loïc Allanos, CSR ... 12 / 07 / 2018

Press Release

Servier joins Embleema's Blockchain Health Consortium to launc... 12 / 04 / 2018

See all news about Servier

CENTRAL TO OUR GROUP’S CORPORATE SOCIAL RESPONSIBILITY.

Created in 2016, the Mécénat Servier Endowment Fund is one of the main aims of our CSR strategy, and a natural extension of our commitment to therapeutic progress to serve patient needs.

Learn more about our forms of commitment, our actions or become a Mécénat Servier’s partner.